175 related articles for article (PubMed ID: 37423640)
1. Bioinformatic analyses reveal the prognostic significance and potential role of ankyrin 3 (ANK3) in kidney renal clear cell carcinoma.
Somsuan K; Aluksanasuwan S
Genomics Inform; 2023 Jun; 21(2):e22. PubMed ID: 37423640
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of
Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
[No Abstract] [Full Text] [Related]
3. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
4. NCF1/2/4 Are Prognostic Biomarkers Related to the Immune Infiltration of Kidney Renal Clear Cell Carcinoma.
Chen Y; He F; Wang R; Yao M; Li Y; Guo D; He S
Biomed Res Int; 2021; 2021():5954036. PubMed ID: 34708124
[TBL] [Abstract][Full Text] [Related]
5. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
[TBL] [Abstract][Full Text] [Related]
6. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
Zou X; Mo Z
Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
[TBL] [Abstract][Full Text] [Related]
7. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma.
Wang J; Jin J; Liang Y; Zhang Y; Wu N; Fan M; Zeng F; Deng F
Front Genet; 2022; 13():978840. PubMed ID: 36186442
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
[TBL] [Abstract][Full Text] [Related]
9. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma.
Yao W; Liu H; Xu F; Cai Z; Hang L; Lu M; Zhao Y; Yang C; Zong Y
Front Genet; 2023; 14():1109991. PubMed ID: 36992705
[No Abstract] [Full Text] [Related]
10. Multi-omics Analysis of Prognostic Significance and Immune Infiltration of FASTK Family Members in Kidney Renal Clear Cell Carcinoma.
Zhong G; Wu D; Chen H; Yan L; Xiang Q; Liu Y; Wang T
Evol Bioinform Online; 2023; 19():11769343231212078. PubMed ID: 38033663
[TBL] [Abstract][Full Text] [Related]
11. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization.
Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y
Front Immunol; 2023; 14():1224904. PubMed ID: 37809090
[TBL] [Abstract][Full Text] [Related]
12. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract][Full Text] [Related]
13. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma.
Chen CC; Chu PY; Lin HY
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154
[TBL] [Abstract][Full Text] [Related]
14. LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma.
Gong Y; Lv Y; Xu F; Xiu Y; Lu Y; Liu Z; Deng L
J Clin Lab Anal; 2022 Sep; 36(9):e24648. PubMed ID: 36082464
[TBL] [Abstract][Full Text] [Related]
15. MKRN1/2 serve as tumor suppressors in renal clear cell carcinoma by regulating the expression of p53.
Yang Y; Luo Y; Huang S; Tao Y; Li C; Wang C
Cancer Biomark; 2023; 36(4):267-278. PubMed ID: 36938725
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and Diagnostic Values of Semaphorin 5B and Its Correlation With Tumor-Infiltrating Immune Cells in Kidney Renal Clear-Cell Carcinoma.
Ding J; Zhao S; Chen X; Luo C; Peng J; Zhu J; Shen Y; Luo Z; Chen J
Front Genet; 2022; 13():835355. PubMed ID: 35480320
[No Abstract] [Full Text] [Related]
17. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
Front Oncol; 2020; 10():570819. PubMed ID: 33628726
[TBL] [Abstract][Full Text] [Related]
18. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis.
Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K
Front Immunol; 2022; 13():903461. PubMed ID: 35663977
[TBL] [Abstract][Full Text] [Related]
19. Overexpressing IFITM family genes predict poor prognosis in kidney renal clear cell carcinoma.
Xu Y; Huang D; Zhang K; Tang Z; Ma J; Zhu M; Xiong H
Transl Androl Urol; 2021 Oct; 10(10):3837-3851. PubMed ID: 34804826
[TBL] [Abstract][Full Text] [Related]
20. FBLN5 as One Presumably Prognostic Gene Potentially Modulating Tumor Immune Microenvironment for Renal Clear Cell Carcinoma in Children and Young Adults.
Zhang M; Chen F; Feng S; Liu X; Wang Z; Shen N; Meng L; Zhu D; Zhu Z
Pharmgenomics Pers Med; 2024; 17():27-40. PubMed ID: 38264064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]